ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,719Medicare Part D Prescriptions Filled, Including Refills

Rank: 347 out of 5176

$1.13M Total Retail Price of All Prescriptions

Rank: 193 out of 5176

404 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 404 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 404 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 11,289 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$89 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
PRAVASTATIN SODIUM 590 510 1 23
AMLODIPINE BESYLATE 522 481 2 2
LEVOTHYROXINE SODIUM 407 360 3 4
CRESTOR 397 375 4 15
OMEPRAZOLE 338 298 5 3
LISINOPRIL 302 269 6 5
BISOPROLOL FUMARATE 258 239 7 239
SIMVASTATIN 229 182 8 1
AMLODIPINE BESYLATE-BENAZEPRIL 224 200 9 55
CARVEDILOL 212 176 10 24
SPIRIVA 204 187 11 54
METFORMIN HCL 200 174 12 7
RAMIPRIL 200 179 12 50
NIASPAN 186 183 14 175
ATORVASTATIN CALCIUM 177 171 15 9
CITALOPRAM HBR 176 141 16 31
DONEPEZIL HCL 175 175 17 28
HYDROCODONE-ACETAMINOPHEN 169 147 S3 18 27
CLOPIDOGREL 165 149 19 26
SYNTHROID 165 135 19 33
METOPROLOL SUCCINATE 161 158 21 11
HYDROCHLOROTHIAZIDE 161 156 21 10
FUROSEMIDE 154 144 23 8
ATENOLOL 145 132 24 12
QUINAPRIL HCL 134 105 25 82
TAMSULOSIN HCL 132 118 26 20
LOVASTATIN 126 114 27 46
DIOVAN 118 118 28 19
ADVAIR DISKUS 117 109 29 32
PLAVIX 114 109 30 29
LOVAZA 113 95 31 43
BUMETANIDE 109 98 32 209
PRADAXA 102 94 33 192
JANUVIA 100 80 34 25
MELOXICAM 99 84 35 53
TRIAMTERENE-HCTZ 96 79 36 86
LEVOXYL 95 84 37 238
ASMANEX 93 83 38 522
CYMBALTA 91 76 39 90
LOSARTAN POTASSIUM 90 90 40 14
WARFARIN SODIUM 87 78 41 13
BYSTOLIC 85 85 42 96
POTASSIUM CHLORIDE 84 78 43 34
CELEBREX 83 71 44 80
METHYLPREDNISOLONE 83 71 44 218
NAMENDA 80 80 46 47
DIOVAN HCT 80 80 46 39
FENOFIBRATE 76 43 48 102
ALENDRONATE SODIUM 75 58 49 18
ZOLPIDEM TARTRATE 73 72 50 17
DIGOXIN 73 65 50 56
GABAPENTIN 71 63 52 21
SYMBICORT 71 70 52 120
GLYBURIDE 66 54 R 54 67
LANTUS SOLOSTAR 66 59 54 70
AZITHROMYCIN 63 53 56 42
CIPROFLOXACIN HCL 61 53 57 84
ESCITALOPRAM OXALATE 61 51 57 89
DEXILANT 59 47 59 118
VESICARE 58 58 60 210
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 54 60 49
EXELON 58 58 60 162
ONGLYZA 58 47 60 153
TRADJENTA 57 57 64 436
FLUTICASONE PROPIONATE 56 42 65 38
LYRICA 55 43 66 133
FAMOTIDINE 52 35 67 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 11, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.